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DOI 10.1186/s12867-015-0030-zRESEARCH ARTICLE Open AccessEfficient 5′-3′ DNA end resection by HerA and
NurA is essential for cell viability in the
crenarchaeon Sulfolobus islandicus
Qihong Huang1,2, Linlin Liu1, Junfeng Liu1, Jinfeng Ni1, Qunxin She2* and Yulong Shen1*Abstract
Background: ATPase/Helicases and nucleases play important roles in homologous recombination repair (HRR).
Many of the mechanistic details relating to these enzymes and their function in this fundamental and complicated
DNA repair process remain poorly understood in archaea. Here we employed Sulfolobus islandicus, a
hyperthermophilic archaeon, as a model to investigate the in vivo functions of the ATPase/helicase HerA, the
nuclease NurA, and their associated proteins Mre11 and Rad50.
Results: We revealed that each of the four genes in the same operon, mre11, rad50, herA, and nurA, are essential for
cell viability by a mutant propagation assay. A genetic complementation assay with mutant proteins was combined
with biochemical characterization demonstrating that the ATPase activity of HerA, the interaction between HerA
and NurA, and the efficient 5′-3′ DNA end resection activity of the HerA-NurA complex are essential for cell viability.
NurA and two other putative HRR proteins: a PIN (PilT N-terminal)-domain containing ATPase and the Holliday
junction resolvase Hjc, were co-purified with a chromosomally encoded N-His-HerA in vivo. The interactions of HerA
with the ATPase and Hjc were further confirmed by in vitro pull down.
Conclusion: Efficient 5′-3′ DNA end resection activity of the HerA-NurA complex contributes to necessity of HerA and
NurA in Sulfolobus, which is crucial to yield a 3′-overhang in HRR. HerA may have additional binding partners in cells
besides NurA.
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Of the various types of DNA lesions, double-strand breaks
(DSBs) are one of the most detrimental, capable of causing
chromosomal rearrangements and eventually cell death if
not repaired appropriately [1]. In eukaryotes, two major
DSB repair pathways are known: non-homologous end
joining (NHEJ) and homologous recombination (HR). The
former is an error-prone process, while the latter mechan-
ism exhibits high fidelity [2]. It has been suggested that in
eukaryotes, DSBs that occur in the G1 phase of the cell
cycle are most likely to be repaired via NHEJ, while those
occurring in the S/G2 phase are preferentially processed
via HRR [2,3].* Correspondence: yulgshen@sdu.edu.cn; qunxin@bio.ku.dk
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unless otherwise stated.HRR has been investigated extensively in bacteria and
eukaryotes. Bacteria encode multiple pathways for DSB re-
pair, including RecBCD, the primary HRR pathway, SbcC-
SbcD, and one backup system, RecFOR [4,5]. The HRR
pathway can be divided into five general steps: (1) recogni-
tion of the break sites and formation of a repair center
(RC), (2) end-processing of the broken ends, (3) loading of
RecA onto single-strand DNA, homology search, and
strand invasion, (4) branch migration and resolution, or
dissolution of the recombination intermediates and rep-
lication restart, and (5) disassembly of the recombin-
ation apparatus and segregation of sister chromosomes
[5]. The eukaryotic HRR machinery is comprised of
a core protein complex containing Mre11-Rad50-Xrs2/
Mre11-Rad50-NBS1(MRX/N); the nucleases/helicases
exodeoxyribonuclease 1 (Exo1/EXO1), Dna2/DNA2, and
Sgs1/BLM; the recombinase Rad51/RAD51; and several
other accessory and regulatory proteins [6]. The HRRThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of the bacterial pathway, but multiple layers of regulation
exist to ensure these repair pathways are accurate and re-
stricted to the appropriate cellular contexts [3]. In eukary-
otes, DSBs are recognized by the MRX(N) complex which
is involved in most DNA end-associated processes includ-
ing damage checkpoint signaling, HR, NHEJ, telomere
maintenance, and meiotic recombination [1]. DNA end
processing is initiated by MRX/MRN in conjunction
with Sae2/CtIP and proceeds along one of the two dis-
tinct pathways, Exo1/EXO1 or Dna2/DNA2-Sgs1/BLM,
forming a long 3′-tail of single-stranded DNA (ssDNA)
that is then utilized in Rad51-dependent strand ex-
change in HR [7-11].
Archaea appear to primarily encode the HRR pathway
for DSB repair, since homologs of several eukaryotic
HRR components have been identified, including Mre11
and Rad50 of the MR complex and the recombinase
RadA [12,13], and homologs of the NHEJ proteins
Ku70/80 are only present in a limited number of ar-
chaeal genomes [14,15]. The RecQ-like helicase Hjm
(Holliday junction migration) and the 5′-flap endo-
nuclease which has both endonuclease and 5′-3′ exo-
nuclease activities have been identified in archaea
[16,17]; however, it is unclear whether they are involved
in dsDNA end resection. Intriguingly, two archaeal
genes, herA and nurA, are implicated in HRR by their
genetic association with mre11 and rad50 in thermo-
philic archaea [18]. This has been supported by bio-
chemical characterization of the encoded proteins:
HerA exhibits ATPase activity and some exhibit dipolar
helicase activities, while NurA is a 5′-3′ ssDNA/
double-stranded (ds) DNA exonuclease and ssDNA
endonuclease [18-22]. Several studies have demon-
strated that Mre11, Rad50, HerA, and NurA are capable
of working in concert to process dsDNA in vitro
[22-26]. Thus, HerA and NurA are regarded as the func-
tional homologs of the eukaryotic Exo1/EXO1, Dna2/
DNA2, and Sgs1/BLM proteins, and the archaeal Mre11-
Rad50-HerA-NurA system can serve as a simple model
system for studying HRR.
The functional role of these putative HRR proteins in
archaea has been investigated only in a few reports
[27-31]. However, gene function is still hypothesized
based on the negative results of genetic analyses, such
as the inability to isolate null mutants for radA, mre11,
rad50, herA, and nurA in Thermococcus kodakaraensis
or radA, herA, and hjm in Sulfolobus islandicus
[29,32,33]. This is due in large part to the fact that suit-
able tools for conducting sophisticated analyses of gene
function in archaea are still lacking. Recently, we re-
ported a genetic complementation test for S. islandicus
based on simvastatin selection [34]. This method can
be utilized to analyze protein function by rescuing anessential gene deletion with expression of a mutant de-
rivative from plasmids.
In this study, we analyzed the necessity of four genes
putatively involved in DSB repair in S. islandicus REY15A,
a genetic model for which the genome has been se-
quenced [35] and versatile genetic tools have been devel-
oped [36]. We revealed that all the four genes, mre11,
rad50, herA, and nurA are essential for cell viability. Fur-
thermore, we demonstrated that the ATPase activity of
HerA, the interaction between HerA and NurA, and the
high 5′-3′ exonuclease activities of the HerA-NurA com-
plex are essential for cell viability. We provide further evi-
dence that HerA and NurA form a complex in vivo. The
co-purification of HerA with a PIN (PilT N-terminal)-
domain containing ATPase and the Holliday junction
resolvase Hjc implies that HerA may also be involved in
the HJ processing.Methods
Strains and growth conditions
Sulfolobus islandicus strain REY15A(E233S) (△pyrEF △lacS)
(hereafter E233S) (Additional file 1: Table S1) [37] was
grown at 75°C in STVyU medium containing mineral
salts, 0.2% (wt/vol) sucrose (S), 0.2% (wt/vol) tryptone
(T), a mixed vitamin solution, 0.005% (wt/vol) yeast
extract (y) and 0.01% (wt/vol) uracil (U), as described
previously [37]. SCVy medium where tryptone was re-
placed by casamino acid (C) was used for cultivating
uracil prototrophic transformants. ATVy medium where
sucrose was replaced with 0.2% (wt/vol) arabinose (A)
was used for protein expression (Additional file 1: Table
S1). The STVyU medium supplemented with 5-fluorotic
acid (5-FOA) (STVyUF) was used for counter-selection
of the pyrEF auxotroph. Phytagel (0.7% [wt/vol]) was
used for making the culture plates. The strains carrying
the simvastatin-resistant selection marker (Additional
file 1: Table S1) were grown in a medium supplemented
with 12 μM simvastatin (Hangzhou Deli Chemical,
Hangzhou, China) as described previously [34].Construction of knockout plasmids
All plasmids used in this study are listed in Additional
file 2: Table S2. The plasmids for gene knockout, pMID-
mre11, pMID-rad50, and pMID-nurA, were constructed
in the similar way as for pMID-herA [34]. All of the
plasmids contained three homologous DNA arms: the
integration (IN) arm, looping-out (OUT) arm, and target
gene (TG) arm. The fragments were amplified using S.
islandicus genomic DNA and their corresponding primers
(Additional file 3: Table S3). After digestion with the
corresponding restriction enzymes, these fragments were
cloned into the knockout vector pMID which contains
pyrEF-lacS selection markers [38].
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Escherichia coli and for the genetic complementation assay
The construction of plasmids for protein expression and
for the genetic complementation assay are described in
Additional file 4: Supplementary methods. Briefly, the
vector pET29a and pSSR carrying a simvastatin-resistant
marker hmg [34] were used as the vectors.Construction of a plasmid for the addition of a
His-tag-coding sequence to 5′ end of chromosomal
herA (in situ His-tagged)
The method for the construction of the plasmid pMIDHis-
herA for HerA in situ His-tagging used the pUC19 as the
original vector similar to that for the knockout plasmids.
The plasmids contained three arms: two copies of L-arm (a
213 bp fragment at the upstream of the herA start codon),
L-arm-1 and L-arm-2, and G-arm (a fragment of 5′ herA
gene). The sequence of L-arm-1 was exactly the same as
L-arm-2. L-arm-1 was cloned into pUC19 at the restric-
tion sites of SalI and MluI yielding pL-arm-1. The herA
gene with N-terminal histidine coding sequence was
amplified from pSeSDA-N-His-HerA (Additional file 2:
Table S2), an expression plasmid carrying herA inserted
at the restriction sites of ClaI and SalI in pSeSD [39],
with the primers 5′-6His-HerA-G-arm F/5′HerA-G-arm-
SphI R. L-arm-2, amplified with the primers 5′HerA L-
arm-1-NcoI F/5′HerA L-arm-2-6His R, was ligated to the
G-arm by SOE PCR. The fragment containing L-arm-2
and G-arm was cloned into pL-arm-1 at the NcoI and
SphI sites yielding the plasmid pMIDHis-herA.Transformation of S. islandicus strains
The expression plasmids or linearized knockout plasmids
were transformed into S. islandicus cells by electropor-
ation as previously described [37].X-gal assay
To detect the presence of the lacS marker in cells, X-Gal
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside)
staining was performed as previously described [34].Mutant propagation assay
The gene necessity was determined by a mutant propa-
gation assay as described with minor modifications [38].
Briefly, 5-FOA was added into the culture of the purified
pMID transformant (pMID-T) at OD600 ~ 0.4 and the
culture continued for counter-selection, resulting in en-
richment culture 1 (En1). Cells of En1 were diluted with
the same fresh media to OD600 ~ 0.1 after they grew to
the stationary phase. The OD600 values were measured
at indicated times until the culture grew to the station-
ary phase or died.Complementation assay of HerA and NurA mutants
pSSR vectors harboring genes encoding wild type HerA,
NurA, or the site-directed mutants were used to comple-
ment the chromosomal herA or nurA deletion. The pSSR
vector was transformed into pMID-herA-T or pMID-
nurA-T and the transformants were selected on STVy
plates supplemented with 12 μM simvastatin (STVy +
sim). Single colonies were subsequently transferred into a
25 ml tube containing 10 ml of STVy + sim medium. After
the culture grew, the cells were spread onto STVyUF +
sim plates for counter selection. The colonies were picked
and individually cultured in a tube containing 10 ml of
STVyUF + sim medium and subsequently inoculated in a
flask containing 50 ml of the same medium.
Genotype verification of the complementation strains by
PCR and sequencing
Sulfolobus genomic DNA of the complementation strain
was extracted from 3 ml of culture using Bacterial DNA
Kit from Omega Bio-Tek (Norcross, GA, USA). The geno-
type at the loci was determined by PCR with the locus
flanking primers.
For verification by sequencing, plasmids were isolated
from 20–30 ml of the Sulfolobus cell cultures with Plas-
mid Mini Kit I (Norcross, GA, USA). The plasmids were
re-transformed to E. coli DH5α for amplification. More
than three E. coli single colonies were picked for plasmid
extraction. The target genes in the plasmids were se-
quenced by BGI (Shenzhen, China).
Protein purification
The pET29a plasmids carrying herA, nurA, or their mutant
genes were transformed into E. coli BL21 (DE3)-Codon-
Plus-RIL for expression. The procedures for induction and
purification of the proteins from E. coli cells were described
in the Additional file 4: Supplementary methods.
To purify HerA from an in situ N-His-tagged HerA
E233S strain, 9 L of the cells cultivated in the STV
medium were collected by centrifugation. The cells were
disrupted by sonication and the soluble fraction was pre-
cipitated by ammonium sulfate (0.6 g/ml). The precipi-
tate was re-suspended in buffer A (50 mM Tris-HCl pH
8.0, 100 mM NaCl) and purified by Ni-NTA column de-
scribed in the Additional file 4: Supplementary methods.
The eluted protein was pooled, concentrated and diluted
in buffer A. The subsequent sample was loaded onto a
Superdex™ 200 10/300 GL column which was pre-
equilibrated with buffer A. The proteins fractions were
analyzed by SDS-PAGE and Western blot.
Analysis of HerA-NurA interaction by gel filtration
chromatography
Physical interactions between HerA and NurA (wild
type and I295L, I295E, F300Y, and F300E mutants) were
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μg) were mixed and incubated at 60°C for 20 min in a
total 500 μl of gel filtration buffer (20 mM Tris pH 8.0,
300 mM NaCl, 5% glycerol, 1 mM DTT). The mixtures
were then spun down to remove any precipitated protein
and loaded onto a Superdex™ 200 10/300 GL column pre-
equilibrated by gel filtration buffer. The fractions (0.5 ml
each) were collected and analyzed by 15% SDS-PAGE.
DNA substrates for the activity assays
Three oligonucleotides were synthesized for preparation
of substrates for the nuclease assays (Additional file 3:
Table S3). Strand E (34-mer in length) was 5′ end labeled
with [γ-32P-ATP] as previously described [22]. The labeled
oligonucleotides were purified with Illustra™ Microspin™
G-25 columns (GE Healthcare, UK). The annealing was
performed as previously described [22]. Various substrates
were constructed by combinations of different oligonucle-
otides (Additional file 5: Table S4). The DNA substrates
were stored at 4°C.
ATPase activity assay
The ATPase activity assay was performed as previously
described. SsDNA, dsDNA, or NurA was added to a
final concentration of 20 nM in the reaction [22].
The nuclease assay of HerA-NurA
The nuclease assay was performed in 20 μl reaction mix-
tures consisting of indicated amounts of wild-type HerA
(or its mutants) and wild-type NurA (or its mutant
D58A), 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM
MgCl2, 1 mM DTT, 1 mM ATP, 0.001% BSA, and 1 nM
[γ-32P]-labeled dsDNA. The mixture was incubated at
65°C for 30 min and then stopped by addition of a 5×
loading buffer (50 mM EDTA, 0.5% SDS, 25% glycerol,
and 0.025% bromophenol blue). The products were sep-
arated by electrophoresis in a native polyacrylamide gel
at 120 V for 90 min in 1 × TBE. To examine the degrad-
ation products of the labeled ssDNA, the sample was ana-
lyzed by a 15% denatured polyacrylamide gel as previously
described [21]. The electrophoresis was run at 300 V for
90 min in 1 × TBE. The gels were exposed to a phosphori-
mager and scanned with Typhoon 9410.
Western blot analysis
Aliquots (50 μl for each) of the gel filtration fractions
were mixed with 5 × SDS-PAGE loading buffer and loaded
onto the gel for SDS-PAGE analysis. The proteins in the
PAGE gel were transferred onto a PDVF membrane at 30
mA for 15 hrs at 4°C. The membrane was washed and in-
cubated with a primary antibody and a secondary antibody
anti-rabbit HRP-conjugate (HuaAn Biotechnology limited
company, Hangzhou, China) following the standard
protocol for Western blot. The protein-specific rabbitpolyclonal antibodies were made by HuaAn Biotechnology
limited company with a 15 aa synthetic peptide specific to
each target protein as immunogens (Additional file 6:
Table S5). The band was visualized with Immobilon™
Western Chemiluminescent HRP Substrate (Millipore
Corporation, Billerica, MA, USA) and the images were
obtained by Imagequant™ 400 (GE Healthcare, UK).
For assessment of HerA and NurA levels in cells by
Western blot, cells from 0.5 ml E233S culture (OD600 ~
0.4) were collected and lysed by mixing with 5 × SDS-
PAGE loading buffer and boiled for 10 min. Total proteins
were separated by SDS-PAGE for Western blot analysis as
described above. Purified proteins were loaded as stan-
dards for quantification.
Results
herA, mre11, rad50, and nurA are all essential for cell
viability
It has been reported that each of the four genes in the
mre11 operon, namely herA, mre11, rad50, and nurA are
possibly essential since deletion mutants were not ob-
tainable (reviewed in Zhang et al. [33]). In these experi-
ments, gene knockouts were tested by construction of a
target gene-specific strain pMID-T and two-step selections
(Figure 1A). A vector pMID (marker insertion and target
gene deletion) containing a marker cassette (pyrEF-lacS)
and three homologous arms (TG-arm, IN-arm and OUT-
arm) specific to the target gene was constructed and a
marker-integrated strain pMID-T was obtained by selec-
tion of a uracil prototroph (Figure 1A). The resulting
strain pMID-T was subjected to the second selection of a
uracil auxotroph by the addition of 5-FOA and uracil into
the culture medium. If the targeted gene is successfully
knocked out, cells are able to grow up easily under the
second selection (Figure 1A). However, no deletion mu-
tant for any of herA, mre11, rad50, or nurA was obtained
after 5-FOA and uracil (Figure 1A).
To affirm the essentiality of the HRR genes, these re-
combinant pMID-T strains were employed in a mutant
propagation assay [38]. If a gene is essential, no deletion
mutant can be obtained, but spontaneous mutation at
pyrEF would occur at a low frequency close to the corre-
sponding rates reported for the protein-encoding genes
of E. coli [40]. The mutant may then accumulate and the
culture will grow, albeit at a slow rate (Figure 1A, bottom
scheme). The culture will stop growing when the original
growth rate is too low for the spontaneous mutants to ac-
cumulate (Figure 1A).
In the current study, two reference strains were used
in the mutant propagation assay: the wild-type strain,
REY15A [41], was used to investigate the growth of spon-
taneous pyrEF mutants, whereas pMID-orc1-3-T was used
to investigate the growth of mutant cells of a nonessential
target gene deletion [42] (Additional file 1: Table S1). It
Figure 1 The four HRR genes, herA, mre11, rad50, and nurA, which are encoded in a single operon, are all essential for cell viability.
(A) Schematic diagram depicting the construction of the strain used in the gene knockout analysis. Marker insertion and target gene deletion
(MID) and a subsequent mutant propagation assay were utilized. The star indicates a putative spontaneous mutation site in pyrEF. (B) Mutant
propagation assay for pyrEF-lacS-integrated transformants (pMID-herA-T, pMID-mre11-T, pMID-rad50-T, and pMID-nurA-T). orc1-3, a nonessential
gene coding for one of the three replication initiation proteins, was used as a positive control, whereas REY15A is a reference for pyrEF mutation.
Strains were cultivated in STVy medium supplemented with 2 mg/ml uracil. The counter selection chemical, 5-FOA, was added when OD600
reached 0.4. The culture was diluted with fresh medium to OD600 ~ 0.1 when the cells had grown to early stationary phase. Absorbance of the
culture was measured.
Huang et al. BMC Molecular Biology  (2015) 16:2 Page 5 of 14has been shown that orc1-3, which encodes a replication
initiator protein, can be deleted in S. islandicus [42]. As
shown in Figure 1B, pMID-orc1-3-T culture grew most
rapidly, followed by the wild-type strain REY15A. Cultures
of pMID-rad50-T, pMID-nurA-T, and pMID-mre11-T
grew much slower than REY15A or not at all (Figure 1B).
As for the wild-type strain REY15A, the growth of these
pMID transformants was not due to deletion of the re-
spective gene, but due to propagation of cells with a muta-
tion in pyrEF (Figure 1A). The strain pMID-mre11-T
never grew. As shown in Figure 1B, up to day 5, the en-
richment of pMID-mre11-T caused the cells to grow more
slowly than the others. We also noticed that colonies of
this strain appeared later than others on plates. The in-
tegration of the marker cassette and OUT arm at the
upstream of mre11 locus may have affected its gene ex-
pression, resulting in growth retardation. The results
demonstrate that all four putative HRR genes are essen-
tial for the viability of S. islandicus.
ATPase activity is essential but not sufficient for the in
vivo function of HerA
Recently, we developed a genetic complementation method
for S. islandicus in which an essential gene deficiency in
the chromosome is able to be rescued by ectopic expres-
sion of the wild-type protein from a plasmid [34]. In this
method, a pMID-T strain (pMID-herA-T) of the target
gene herA as described above was transformed with a pSSR
plasmid (harboring a simvastatin resistance marker and
expressing the wild-type gene) under selection by sim-
vastatin. Upon selection of the transformed strain with
uracil, 5-FOA, and simvastatin, the essential chromo-
somal gene together with the pyrEF-lacS maker was
looped out by intra-chromosomal recombination, and the
plasmid was maintained in the absence of antibiotics.Here we employed that system to test the possibility of
rescuing herA deficiency with different HerA mutant
proteins, and investigated the functions of the residues
critical for various properties, including ATPase activity of
HerA, nuclease activity of the HerA-NurA complex, and
the interaction between HerA and NurA.
In vitro site-directed mutagenesis of archaeal HerA
proteins has revealed conserved amino acid residues
critical for its ATPase and helicase activities [18,22,23].
These amino acid residues are K154, D176, E356, and
R381 of S. islandicus HerA, among which K154 and
E356 are located in the Walker A and Walker B motifs,
respectively. Point mutations at the four conserved sites
were introduced by site-directed DNA mutagenesis and
mutant genes encoding K154R, D176E, D176N, E356D,
E356Q, or R381K substitutions were cloned into pSSR
to create genetic complementation plasmids (Additional
file 2: Table S2). The genetic host used for the experi-
ment was pMID-herA-T, the recombinant strain carrying
a marker-target gene cassette (pyrEF-lacS-herA) at the
locus of herA gene (Figure 2A). A complementation plas-
mid was introduced into the host via transformation, and
transformants were obtained by simvastatin selection.
Strikingly, only the transformants harboring pSSR,
pSSRA-HerA or pSSRA-D176E were obtained, while no
transformants with pSSR carrying any of other five mu-
tants grew successfully after transformation. We have
shown that ectopic wild type HerA was expressed in
higher amounts in the cell than chromosomal HerA [34].
It is likely that the mutant protein was also in much
higher abundance than the chromosome-coded HerA in
the cells if the cells were transformed with the plasmid
and the gene expression was induced. Loss of the ATPase
and helicase activity in the HerA mutant was highly lethal
to the cells. In a recent report, an in vitro mutant-doping
Figure 2 A HerA(D176E) mutant with reduced ATPase activity is able to complement deletion of the wild-type herA gene. (A) A
schematic map depicting the procedures of the complementation analysis. pMID-herA-T cells were transformed with pSSR vectors. The cells
were selected in the presence of simvastatin. Counter-selection was performed with solid medium containing 5-FOA, uracil, and simvastatin. Two
genotypes of the cell grown up were indicated as ➀ and ➁. The star indicates a putative spontaneous mutation in pyrEF. (B) Genotype analysis
of cells by PCR using herA flanking primers. The genomic DNA of each strain was isolated and used as the template. The pSSR plasmids in cells
were isolated and amplified in E. coli DH5α for sequencing. Left panel, a schematic map showing the lengths of PCR products of different strains.
Right panel, agarose gel electrophoresis of the PCR products. “+”, the designed plasmid maintained. (C) ATPase activity of HerA alone or with
NurA in the absence or presence of DNA. The assay was performed as described in the Methods. Reaction products were separated using thin
layer chromatography and analyzed by Phosphorimager. The means ± standard errors of three independent experiments and p values (n = 3)
are shown. (D) ATPase activity of wild-type and mutant HerA proteins. The means ± standard deviations of three independent experiments
are shown.
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K154A to WT HerA resulted in an exponential drop in
the proportion of unwound DNA substrate, where the ra-
tio of 1:1 almost inactivated the unwinding activity [43].
The result is consistent with our in vivo data. Our results
are also in good agreement with the above result that herA
is essential for cell viability.
The three transformants above were then subjected to
counter-selection against pyrEF on plates supplemented
with uracil, 5-FOA, and simvastatin (Figure 2A). As shown
in Figure 2B, two genotypes survived the selection. One
genotype represents a ΔherA carrying plasmid harboring
pSSRA-HerA or pSSRA-D176E and the other represents
pMID-herA-T cells carrying a pyrEF mutation with the
empty vector pSSR (Figure 2A). PCR and sequencing
confirmed that the culture with pSSRA-HerA(D176E)contained a deleted chromosomal herA allele as that of
pSSRA-HerA, and the plasmid carried the D176E herA
substitution (Figure 2B). Thus, these results demonstrate
that only wild type HerA and HerA(D176E) could func-
tionally complement herA deficiency in vivo under the
assay conditions.
To gain insight into why only D176E could rescue S.
islandicus cells with a chromosomal herA deletion, all
six HerA mutant derivatives were expressed in and puri-
fied from E. coli. We showed that the wild type HerA
was able to hydrolyze approximately 1.8 mole of ATP
per mole of enzyme per min. The ATPase activity of
HerA was enhanced in the presence of either ssDNA, 3′-
overhang, or blunt-ended dsDNA (Figure 2C). In addition,
the ATPase activity of HerA was not enhanced in the
presence of NurA (Figure 2C). Except for D176E and
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tants was very low or undetectable. D176E and E356D
maintained about one-seventh and one-fifth the activity of
the wild-type enzyme, respectively (Figure 2D). Notably,
the ATPase-active mutant E356D could not rescue the
chromosomal deficiency of HerA, which was further stud-
ied (see below). Taken together, these results indicate that
ATPase activity is essential, but not sufficient on its own,
for the in vivo function of HerA.
Nuclease activity is essential for the in vivo function of NurA
Previous works established that a few amino acid resi-
dues in NurA are critical for its enzyme activity. The
corresponding residues are D58, E116, and D133 of S.
islandicus NurA [26,44]. Another residue (K202 in S.
islandicus) critical for the enzyme activity was revealed
by crystallization analysis of S. solfataricus NurA. It is
located near the active site of the NurA and substitution
of the corresponding residue in S. solfataricus yielded
an inactive enzyme, indicating that the lysine residue is
possibly involved in the catalysis [26]. Since the NurA
proteins from S. solfataricus and S. islandicus exhibit
high identity (90%) in their amino acid sequences, the
conserved residues should function in the same way.
Therefore, we focused on two of the residues D58 and
K202 and addressed the necessity of NurA nuclease ac-
tivity using the same approach employed for HerA. The
empty vector and pSSR carrying genes encoding the
wild type NurA or its mutants D58E, D58A, K202R, and
K202A were constructed and transformed into pMID-
nurA-T cells. Surprisingly, all of the transformants grew
under simvastatin selection, not only for the empty vec-
tor and pSSR carrying the wild type gene, but also for all
the four mutants. After subsequent counter-selection by
5-FOA, colonies were selected from the plates and culti-
vated for further analyses. PCR analyses showed that the
chromosomal nurA had been deleted in all strains sup-
plemented with NurA (wild type or mutants), while that
supplemented with the empty vector had not been de-
leted (Figure 3A and 3B).
Subsequently, nurA on the complementation plasmid
was amplified and sequenced from each nurA-rescued
strain. Intriguingly, all plasmids carried the wild-type
nurA gene rather than any of the various mutant nurA
genes cloned into the pSSR vector. This process was re-
peated three times, and the same results were obtained
each time. Therefore, we conclude that the nurA mu-
tants reverted to the wild-type during the experiment.
Since reverse mutation occurs at a very low rate, we
reasoned that the nurA mutant complementation plas-
mids could not rescue nurA deficiency in this archaeon.
Furthermore, NurA and HerA work as a complex for
dsDNA end processing in S. solfataricus and the NurA
(K202A) mutant did not affect the interaction [26],suggesting that the inability to rescue nurA deficiency
was not due to failure in the complex formation. Our re-
sults provide evidence supporting the hypothesis that
nuclease activity is essential for the in vivo function of
NurA. The reason why the plasmid carrying lethal NurA
mutant existed in the cell but not for HerA mutants is
not quite clear. We assume that the cells carrying plasmid
with lethal NurA mutant have the possibility to assemble
a functional NurA as a dimer, allowing the presence of the
plasmid and the reversion to occur. While for the cells
carrying plasmid with lethal HerA mutant, incorporation
of a lethal deficient subunit into HerA hexamer could re-
sult in a non-functional HerA. As a result, the probability
of assembling a functional HerA as a hexamer should be
much lower than that for NurA as a dimer, and the cells
would not likely survive.
Interaction between NurA and HerA is essential to cell
viability
A biochemical study has shown that in S. solfataricus,
NurA interacts with HerA, forming a complex for dsDNA
end processing [26]. Two NurA residues (I295 and F300),
both found on a hydrophobic surface according to the
protein’s crystal structure, have been implicated in the
HerA-NurA interaction, as mutation at either residue to
glutamic acid abolishes formation of the complex [26].
To address the importance of the HerA-NurA inter-
action in vivo, pSSR plasmids carrying four S. islandicus
NurA mutants, I295L, I295E, F300Y, and F300E, were in-
dividually transformed into pMID-nurA-T cells to test for
complementation. I295L and F300Y were able to achieve
complementation (Figure 3B), whereas I295E and F300E
failed to do so. Plasmid sequencing confirmed that each
plasmid carried the original mutant nurA substitution. It
is notable that the changes from isoleucine and phenyl-
alanine to leucine and tyrosine (I295L and F300Y) do not
affect the hydrophobic character at the interaction surface
between NurA and HerA, whereas the I295E and F300E
substitutions do. We speculated that NurA I295L and
F300Y mutants should maintain the interaction, while
I295E and F300E should not. To test this, the interaction
between the HerA and NurA mutants I295L, I295E,
F300Y, and F300E of S. islandicus were experimentally
evaluated by gel filtration, confirming that I295L and
F300Y maintained the interaction and complex forma-
tion while I295E and F300E did not (Figure 3C). It is in-
teresting that the pSSR plasmid carrying NurA(I295E)
or F300E was maintained in cells. We assume that I295E
or F300E are not as toxic as the nuclease-dead NurA mu-
tants (D58E, D58A, K202R, and K202A) since they were
unable to interact with HerA and did not interfere with
the DNA end resection process. The plasmid with either
NurA mutant could exist in the cell and there is no
selection for generation of the reversion genotype. Taken
Figure 3 The nuclease activity of NurA and its interaction with HerA are essential for cell viability. (A) A schematic map depicting the
procedures of the complementation analysis. pMID-nurA-T cells were transformed with pSSRA-NurA-C-His plasmids or empty vector. Three
genotypes of the cells grown up after counter-selection were indicated as ➀, ➁, and ➂. The star indicates a putative spontaneous mutation in
pyrEF. (B) Genotype analysis of the cells grown up by PCR using nurA flanking primers and sequencing of the nurA on the isolated plasmid. “+”,
the designed plasmid maintained; “R”, plasmid maintained, but nurA gene had reverted to wild-type. (C) Gel filtration analysis of the interaction
between wild type HerA and NurA mutants I295L, I295E, F300Y, and F300E by a Superdex™ 200 10/300 GL column. A total of 500 μg HerA, 500
μg NurA, and the mixture were heated incubated at 60°C for 20 min before gel filtration. The sample fractions were analyzed by SDS-PAGE. A
small amount of NurA formed dimers in gels when NurA concentration was high. The elution peaks of the molecular markers are indicated by
arrows at the bottom.
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and HerA is essential for cell viability.
The HerA(D176E)-NurA complex, but not the HerA
(E356D)-NurA complex, retains 5′-3′ DNA resection activity
in vitro
As described above, although HerA(E356D) showed a
higher level of ATPase activity than D176E, only HerA
(D176E) rescued herA deficiency. Here, we further charac-
terized the two mutant proteins. The activities of HerA,
NurA, and their complex were examined using a 3′-over-
hang or blunt-ended DNA as the substrate (Additional file
3: Table S3 and Additional file 5: Table S4). The substrates
were labeled, as illustrated in Figure 4A and Additional
file 5: Table S4, and products and substrates were ana-
lyzed by native as well as denaturing polyacrylamide gel
electrophoresis. The native gels were used to investigate
both endonuclease and exonuclease activities whereasdenaturing gels were used to investigate exonuclease ac-
tivity of the substrates.
We first investigated the DNA degradation activity of
the wild-type HerA and NurA. In the absence of ATP, the
HerA-NurA complex failed to degrade any of the DNA
substrates, indicating that the nuclease activity of NurA
was dependent on the ATP hydrolysis by HerA (Additional
file 7: Figure S1B). Furthermore, HerA also lost its helicase
activity when it was alone or combined with nuclease-dead
NurA protein (Additional file 7: Figure S1D). This indicates
that the DNA degradation activity of HerA and NurA re-
lies on both ATPase (and/or helicase) activity of HerA and
the nuclease activity of NurA, in agreement with a previous
report [26]. HerA-NurA complex degraded 3′-overhang
and blunt-ended DNA in the 5′-3′ direction, although it
also exhibited partial endonuclease activity on 3′-over-
hang DNA (Additional file 7: Figure S1B and S1C). Subse-
quently, since we were unable to detect the helicase
Figure 4 HerA(D176E)-NurA maintains strong 5′-3′ exonuclease activity. (A) A schematic diagram of the nuclease activity of the HerA-NurA
complex using two different substrates. (B) Represent gel profiles showing the nuclease activity of HerA-NurA complexes. Wild-type or mutant
HerA (27.8 nM hexamer) was mixed with NurA (83.4 nM dimer) for 30 min at 65°C. After the reactions, the products were analyzed on a 10%
native polyacrylamide gel. (C) Same as in (B), but the products were analyzed on a 15% denaturing polyacrylamide gel. “+”, wild-type HerA or
NurA. ➀-➅,site-directed HerA mutants: K154R, D176E, D176N, E356D, E356Q, and R381K. B, boiled sample.
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ation activity of various HerA mutants complexed with
wild-type NurA was analyzed (Figure 4). For blunt-ended
substrates, the 5′-3′ exonuclease activity of D176E-
NurA was similar to wild-type HerA-NurA (Figure 4B
and 4C, lanes 14 and 16; Figure 5B). For 3′-overhang
substrate, D176E-NurA exhibited higher exonuclease
activity (Figure 4C, lanes 4 and 6; Figure 5A) and endo-
nuclease activity (Figure 5A) than the wild-type HerA-
NurA, while for both substrates, R381K-NurA were
unable to degrade DNA. This was thought to be due to
loss of ATPase activity (Figure 4B and 4C, lanes 10 and
20). K154R-NurA, D176N-NurA, and E356Q-NurA ex-
hibited much lower activity than wild-type HerA-NurA
or were completely inactive (Figure 4B and 4C, lanes 5,
7, 9, 15, 17, and 19; Figure 5). Importantly, we found
E356D-NurA exhibited nuclease activities distinct from
both wild-type HerA-NurA and HerA(D176E)-NurA.
E356D-NurA maintained endonuclease activity on the
3′-overhang substrate but with less than half of theexonuclease activity of the wild type on any of the sub-
strate (Figure 4B and 4C, lanes 8 and 18; Figure 5). Since
we have shown that only HerA(D176E) rescued the defi-
ciency of the chromosomal herA but HerA(E356D) did
not, these results reveal, for the first time, that high 5′-
3′ exonuclease activity of HerA-NurA is essential for
cell viability.
HerA interacts with NurA in vivo
To further investigate the in vivo role of HerA, we
conducted in situ poly-histidine (His)-tagged protein
purification. This method facilitated the isolation of
HerA-interacting proteins in S. islandicus cells under
physiological growth conditions. Using a recombination
scheme similar to marker insertion and target gene dele-
tion (MID), the chromosomal version of herA was replaced
with an N-His-tagged version of herA (Figure 6A). The
resulting strain was confirmed by PCR using herA locus-
specific flanking primers and X-gal staining (Figure 6B).
His-tagged HerA and associated proteins were co-purified
Figure 5 The time courses of the exonuclease and endonuclease activities of HerA-NurA complexes on dsDNA. The assay was performed
in 20 μl reaction mixture as described in the Methods. The reactions were stopped at the indicating times by the addition of 5× loading buffer
and putting the tubes on ice. The representative gels and the means ± standard deviations of three independent experiments are shown.
(A) 3′-overhang. (B) blunt-ended DNA.
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precipitation, nickel-nitrilotriacetic acid (Ni-NTA) affin-
ity purification, and gel filtration (Figure 6C). Purified
proteins were analyzed by SDS-PAGE and Western
blotting. Western blot analysis using protein-specific
antibodies revealed that NurA eluted in same fractions
with HerA (Figure 6D). The fractions containing HerA
were pooled, concentrated, and analyzed further by li-
quid chromatography-mass spectrometry. Strikingly, we
identified two other proteins co-purified with HerA, Hjc
(Holliday junction cleavage, SiRe_1431) and a PIN-domain
ATPase (SiRe_1432). Western blot analysis showed that
HerA, Hjc, and the PIN-domain ATPase were present in
earlier fractions of the co-purified sample than that of
HerA and NurA (Figure 6D). However, the HRR proteins,
Mre11, Rad50, and RadA, were not found in either MS(data not shown) or Western blot analyses (Figure 6D).
The interaction between HerA and the PIN-domain
ATPase or Hjc may be weak in the absence of other fac-
tors as shown in an in vitro pull-down assay (Figure 6E
and 6F). The results support that HerA forms a complex
with NurA in vivo and suggest that HerA has additional
partners in the cell.
Discussion
Essentiality of the mre11 operon and the 5′-3′ exonuclease
activity of the HerA-NurA complex
Previous works suggested that each gene in the mre11
operon could be essential in S. islandicus and T. koda-
karaensis. However, the gene essentiality in T. kodakar-
aensis, an archaeon belonging to euryarchaeota, one of
the two main branches of archaea, was deduced from
Figure 6 Identification of co-purified proteins using a chromosomally-coded His-tagged HerA. (A) Schematic diagram showing the
construction of a strain that can encode a N-terminal His-tagged HerA by modification of the chromosomal herA. The MID strategy was used for
the construction. (B) Confirmation of the constructed strain using PCR and X-gal staining. herA locus-specific flanking primers were used for PCR
amplification. 1, the control strain E233S; 2, the constructed strain pMIDHis-herA-T. (C) Schematic map showing the purification of the proteins.
(D) Western blot analyses of in situ N-His-tagged HerA and its co-purified proteins with specific antibodies. The fractions of 8, 9, 10, and 11 ml
collected from the gel filtration were analyzed. C, purified protein. The standard molecular mass markers are indicated with arrows. (E) Pull-down assay
confirming the interaction between HerA and the ATPase. A total of 50 μg HerA-C-His (or HerA) was mixed with 50 μg ATPase (or ATPase-C-His) at
70°C for 30 min in a buffer containing 25 mM Tris-HCl, pH 9.0, and 200 mM NaCl. The mixture was incubated with nickel-agarose beads.
Unbound proteins were washed with the buffer above supplemented with 25 mM imidazole and target proteins were eluted by 250 mM
imidazole. The fractions were detected by western blot with protein-specific antibodies. (F) Detection of the interaction between HerA and
Hjc by pull-down assay. The procedure was as those used in (E). A total of 42 μg HerA-C-His and 12 μg Hjc were used in the assay.
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whereas only an overview has been presented for the gen-
etic study for the HRR genes in S. islandicus, an archaeon
belonging to crenarchaeota, another main branch of ar-
chaea [29,32,33]. Here, we have evaluated the gene essen-
tiality of the four genes in S. islandicus individually, using
a mutant propagation assay previously developed in our
laboratory [38]. We found that mutant cells generated
from the pMID transformants (pMID-T) lost their propa-
gation capability, strongly demonstrating that each of the
genes in this operon is essential for cell viability of S.
islandicus. Our previous studies have revealed that a
RecQ-like DNA helicase Hjm and RadA, the archaeal
homolog of Rad51, are essential in this archaeon [32,33].
These results indicate that all these HRR genes are essen-
tial for the viability of S. islandicus. Strikingly, hyperther-
mophilic archaea are the only known organisms among
microorganisms, in which the mre11, rad50, and radA are
absolutely required for cell growth.We attempted to quantify the levels of HerA and NurA
in the cell by quantitative Western blot analysis and found
that the amounts were about 956 ± 30 and 848 ± 40 mole-
cules per cell for HerA and NurA, respectively (Additional
file 8: Figure S2). These are much higher than that for
RecBCD, a DNA end resection complex in E. coli, which
is only about 10 molecules per cell [45]. This may indicate
that a large number of DSBs exist in Sulfolobus which
need to be repaired constantly and efficiently. In re-
sponse to the essential requirement of DSB processing,
HerA and NurA may be constitutively expressed in high
levels in the cells.
The essentiality of the activities of the HRR proteins in
this organism was further characterized using a genetic
complementation assay recently developed in our labora-
tory [34]. We have found that the ATPase activity of HerA
and the efficient 5′-3′ degradation activity by the HerA
and NurA complex is essential for cell viability in S. islan-
dicus and this should reflect the in vivo activity of the
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have high exonuclease activity and could maintain the es-
sential function of HerA in vivo. Another mutant (E356D)
of HerA and NurA wild-type protein complex maintain
the ssDNA endonuclease activity of the wild type enzyme
complex, but with much reduced exonuclease activity. We
have shown that HerA(E356D) did not complement the
essential function of the protein complex and therefore
the endonuclease activity apparently does not reflect the
in vivo essentiality of the helicase/nuclease complex;
however, the exonuclease to generate ssDNA does. The
ssDNA generated during DSB end resection is a critical
intermediate for strand invasion in eukaryote. It could also
be utilized in a synthesis-dependent strand-annealing
pathway (SDSA) [46]. Therefore, although the ssDNA is
mostly likely employed in HRR in archaea, the possibility
that it is a substrate for other processes such as a putative
SDSA can not be ruled out.
Roles of the conserved residues of HerA
We revealed that out of the six HerA mutants, only
HerA(D176E) could maintain the essential function of
HerA in vivo. Both HerA(K154R) and HerA(R381K) lost
the ATPase activity of HerA, confirming the importance
of the Walker A and arginine finger motif in ATP hy-
drolysis for DNA helicase [47-49]. It was recently shown
that E356 of the Walker B motif in S. solfataricus HerA
forms a salt bridge with trans-acting R381. This inter-
action is thought to be necessary for both stable inter-
face formation and water activation prior to catalysis
[43]. The change of glutamate acid (E) to glutamine (Q)
may impair the formation of the salt bridge leading to
loss of the ATPase activity. Furthermore, HerA(E356D)-
NurA maintained the same level of the endonuclease
activity as the wild type, but had much lower 5′-3′ exo-
nuclease activity on dsDNA. E365 may be also involved
in fine coupling of ATP hydrolysis and DNA unwinding.
Slight change of the residue from glutamic acid to aspar-
tic acid could lead to coupling impairment resulting in
the reduction of the 5′-3′ resection of HerA(E356D)-
NurA. In agreement with this, S. solfataricus HerA struc-
ture showed that ATP binding, hydrolysis, and release led
to the local changes in the positioning of R381, which
resulted in DNA-binding loop movement and substrate
translocation [43]. The E356D mutant may maintain the
salt bridge with R381 for ATP binding and hydrolysis, but
affect the changes of R381 positioning, which would im-
pair its DNA unwinding activity. Finally, we showed that
HerA(D176N) exhibited as low ATPase activity as that of
E356Q. The conserved residue D176 in S. solfataricus
HerA locates close to the ATP-binding site. Our results
suggest that mutation to either glutamic acid or aspara-
gine affects the ATP activity, and is in good agreement
with the structural prediction of HerA.The end resection activity requires both HerA and NurA
It is surprising that we could not detect the helicase ac-
tivity of HerA or the nuclease activity of NurA, even
though various reaction conditions were applied in our
assay. The DNA end resection activity on dsDNA was
only observed in the presence of both HerA and NurA
(Additional file 7: Figure S1B and S1D). The result was
consistent with that in S. solfataricus and P. furiosus
[23,26]. However, the helicase activity of HerA and the
nuclease activity of NurA could be detected using the
HerA and NurA proteins from S. tokodaii and S. acido-
caldarius [18,19,22,44]. Due to the closer phylogenetic
relationship of S. islandicus to S. solfataricus than that
to either S. tokodaii or S. acidocaldarius, it may be rea-
sonable that the properties of S. islandicus HerA and
NurA proteins resemble to their counterparts in S. solfa-
taricus. It may indicate that the mode of end resection
by HerA and NurA in S. islandicus and S. solfataricus is
different from that of S. tokodaii and S. acidocaldarius.
Further study on how HerA interacts with NurA for
dsDNA end resection and how the length of the resected
ssDNA is controlled will reveal the detailed mechanisms
of DNA end processing in archaea.
Conclusion
Our results revealed that the high 5′-3′ DNA end resec-
tion activity of HerA-NurA complex is essential for cell
viability. This may indicate that a large number of DSBs
occurs in Sulfolobus cells under high temperature condi-
tions need to be efficiently resected. Two other HerA-
interacting proteins, an ATPase and Hjc, were identified,
suggesting that HerA have other roles in addition of that
in DNA end resection. These results will help better
understand HRR in thermophilic archaea.
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